Medexus Pharmaceuticals Inc. (MEDXF) PT Lowered to $7 at Roth Capital
Tweet
Share
E-mailGet Alerts MEDXF Hot Sheet
Price: $3.79 -1.04%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Roth Capital analyst Scott Henry lowered the price target on Medexus Pharmaceuticals Inc. (OTC: MEDXF) to $7.00 (from $8.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
